JPWO2021195591A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021195591A5
JPWO2021195591A5 JP2022558098A JP2022558098A JPWO2021195591A5 JP WO2021195591 A5 JPWO2021195591 A5 JP WO2021195591A5 JP 2022558098 A JP2022558098 A JP 2022558098A JP 2022558098 A JP2022558098 A JP 2022558098A JP WO2021195591 A5 JPWO2021195591 A5 JP WO2021195591A5
Authority
JP
Japan
Prior art keywords
seq
expression construct
artificial expression
composition
injection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022558098A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518980A (ja
JP2023518980A5 (https=
JP7749577B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/024525 external-priority patent/WO2021195591A2/en
Publication of JP2023518980A publication Critical patent/JP2023518980A/ja
Publication of JPWO2021195591A5 publication Critical patent/JPWO2021195591A5/ja
Publication of JP2023518980A5 publication Critical patent/JP2023518980A5/ja
Priority to JP2025157795A priority Critical patent/JP2026001073A/ja
Application granted granted Critical
Publication of JP7749577B2 publication Critical patent/JP7749577B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022558098A 2020-03-27 2021-03-26 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物 Active JP7749577B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025157795A JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063001159P 2020-03-27 2020-03-27
US63/001,159 2020-03-27
PCT/US2021/024525 WO2021195591A2 (en) 2020-03-27 2021-03-26 Artificial expression constructs for selectively modulating gene expression in non-neuronal brain cells

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025157795A Division JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Publications (4)

Publication Number Publication Date
JP2023518980A JP2023518980A (ja) 2023-05-09
JPWO2021195591A5 true JPWO2021195591A5 (https=) 2024-02-27
JP2023518980A5 JP2023518980A5 (https=) 2024-02-27
JP7749577B2 JP7749577B2 (ja) 2025-10-06

Family

ID=77890746

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022558098A Active JP7749577B2 (ja) 2020-03-27 2021-03-26 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物
JP2025157795A Pending JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025157795A Pending JP2026001073A (ja) 2020-03-27 2025-09-24 非神経脳細胞での遺伝子発現を選択的に調節する人工発現構築物

Country Status (6)

Country Link
US (1) US20230117172A1 (https=)
EP (1) EP4127182A4 (https=)
JP (2) JP7749577B2 (https=)
AU (1) AU2021242353A1 (https=)
CA (1) CA3173609A1 (https=)
WO (1) WO2021195591A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3207224A1 (en) * 2021-02-02 2022-08-11 Bryan GORE Artificial expression constructs for modulating gene expression in gabaergic neurons and astrocytes
WO2023060112A1 (en) * 2021-10-05 2023-04-13 Allen Institute Artificial expression constructs for modulating gene expression in the cerebellum and a secondary cell type
JP2025520385A (ja) * 2022-06-13 2025-07-03 アレン インスティテュート 中枢神経系の非神経細胞において遺伝子発現を調節するための人工発現コンストラクト

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6602680B2 (en) 2000-07-14 2003-08-05 The Regents Of The University Of California Production of gabaergic cells
US20060127358A1 (en) 2002-05-01 2006-06-15 Nicholas Muzyczka Raav expression systems and methods for enhancing transduction of mammalian neural cells
US20080039413A1 (en) * 2003-10-21 2008-02-14 Morris David W Novel compositions and methods in cancer
EP4154903A1 (en) * 2008-04-22 2023-03-29 Vib Vzw Liver-specific nucleic acid regulatory elements and methods and use thereof
WO2013155222A2 (en) * 2012-04-10 2013-10-17 The Regents Of The University Of California Brain-specific enhancers for cell-based therapy
CN110546257B (zh) * 2017-03-17 2024-03-01 阿德夫拉姆生物技术股份有限公司 用于增强基因表达的组合物和方法
WO2019068854A1 (en) * 2017-10-06 2019-04-11 Ospedale San Raffaele S.R.L. GENE THERAPY OF NEURODEGENERATIVE DISEASES USING VAA VECTORS
US11364309B2 (en) 2017-11-10 2022-06-21 Norwegian University Of Science And Technology (Ntnu) Neuronal enhancers
AU2019253700B2 (en) * 2018-04-09 2025-08-14 Allen Institute Rescuing voltage-gated sodium channel function in inhibitory neurons

Similar Documents

Publication Publication Date Title
JP7707261B2 (ja) 筋疾患の治療のための改変aavカプシドポリペプチド
US20020172663A1 (en) Localized myocardial injection method for treating ischemic myocardium
US20230048025A1 (en) Adeno associated viral vectors
JP2025023947A5 (https=)
CN109844124A (zh) 年龄相关疾病和病症的基因治疗方法
JP2014221789A (ja) Aavベクターの末梢注入を使用する広範囲におよぶ運動ニューロンへの遺伝子の送達
US20250032550A1 (en) A novel way for brain-specific delivery of molecules for the treatment of brain diseases
UA112841C2 (uk) Вектор та послідовність для лікування мукополісахаридозів
KR20240110849A (ko) Aadc/gdnf 폴리뉴클레오티드 및 이의 파킨슨병 치료에 있어서의 용도
KR102616559B1 (ko) N-아세틸갈락토사민 결합 폴리펩티드에 기초한 mRNA 표적 분자 및 이의 제조 방법
WO2004035779A1 (ja) ウイルスエンベロープを用いた生体分子の導入方法ならびにそのための組成物およびシステム
JPWO2021195591A5 (https=)
JP2022058346A (ja) グルコーストランスポーター1発現用アデノ随伴ウイルスベクター
JPWO2020076614A5 (https=)
JPWO2020227166A5 (https=)
JPWO2022246276A5 (https=)
CN109069669A (zh) 载体
JPWO2021248085A5 (https=)
KR102828335B1 (ko) Gne 근육병 치료용 aav 기반의 유전자 치료제
CN116590342B (zh) 一种aav载体及其应用
US20020193335A1 (en) Gene therapy for neurological tissues
TWI857661B (zh) 利用奈米膠囊藥物傳送系統且用於產生食慾素神經肽的組合物及其用於製備藥物的用途
US20240398722A1 (en) Compositions and methods for producing orexin neuropeptide using nanocapsule-based drug delivery system
CN121344099A (zh) 一种小鼠心肌纤维化病理模型诱导剂
US20240148830A1 (en) Treatment of Neurological Disorder Using NHR